We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
118 hedge funds and large institutions have $356M invested in Puma Biotechnology in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
28% more call options, than puts
Call options by funds: $726K | Put options by funds: $569K
2.17% more ownership
Funds ownership: 88.8% → 90.97% (+2.2%)
2% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 43
2% less capital invested
Capital invested by funds: $362M → $356M (-$6.56M)
4% less funds holding
Funds holding: 123 → 118 (-5)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
118
Holders Change
-5
Holders Change %
-4.07%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
44
Reduced
43
Closed
15
Calls
$726K
Puts
$569K
Net Calls
+$157K
Net Calls Change
-$978K
Top Buyers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$10.8M |
| 2 |
GC
Globeflex Capital
San Diego,
California
|
+$4.17M |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$2.53M |
| 4 |
FAM
Fred Alger Management
New York
|
+$2.35M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.8M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$5.16M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$3.18M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$2.45M |
| 4 |
DM
Deerfield Management
New York
|
-$2.12M |
| 5 |
Axa
Paris,
France
|
-$1.85M |
